Scientists map how drugs travel from mother to baby
NCT ID NCT02020083
Summary
This study aimed to understand how a key HIV drug, tenofovir, passes from a pregnant person to the fetus through the placenta. Researchers used a lab model of the placenta to measure this transfer and see if other medications or natural body processes affect it. The goal was to gather knowledge to help optimize drug dosing for preventing mother-to-child HIV transmission.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANT WOMEN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Maternité de Port Royal
Paris, France
Conditions
Explore the condition pages connected to this study.